Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review

doi:10.4254/wjh.v17.i6.104761

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-7)

Tables (1-2)

Sum=2

Jun 27, 2025 (publication date) through Jun 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Jun 27, 2025; 17(6): 104761
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.104761

Full Size Figure Download Figure

Figure 3 A schematic summary of the rule of five from the BAVENO VII consensus. BMI: Body mass index; cACLD: Compensated advanced chronic liver disease; CSPH: Clinically significant portal hypertension; MASLD: Metabolic dysfunction-associated steatotic liver disease.

Citation: Xie XY, Benmassaoud A. Advances in the diagnosis and management of clinically significant portal hypertension in cirrhosis: A narrative review. World J Hepatol 2025; 17(6): 104761
URL: https://www.wjgnet.com/1948-5182/full/v17/i6/104761.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i6.104761